OVEREXPRESSION OF BASIC FIBROBLAST-GROWTH-FACTOR IN MCF-7 HUMAN BREAST-CANCER CELLS - LACK OF CORRELATION BETWEEN INHIBITION OF CELL-GROWTHAND MAP KINASE ACTIVATION
R. Wieder et al., OVEREXPRESSION OF BASIC FIBROBLAST-GROWTH-FACTOR IN MCF-7 HUMAN BREAST-CANCER CELLS - LACK OF CORRELATION BETWEEN INHIBITION OF CELL-GROWTHAND MAP KINASE ACTIVATION, Journal of cellular physiology, 177(3), 1998, pp. 411-425
Basic fibroblast growth factor (bFGF, FGF-2) is progressively lost fro
m mammary epithelial cells as they become malignant. To investigate th
e effects of restoring the expression of bFGF in breast cancer cells,
we constructed MCF-7 cells that permanently overexpress 18-kD cytoplas
m-localizing bFGF (MCF-7/Delta A(FCF(18)) cells) and cells that expres
s both the 18-kD along with the 22- and 24-kD nucleus-localizing bFGF
peptides (MCF-7/NCFFGF(18,22,24) cells), using retroviral transduction
. These stable cell constructs grew more slowly and had a larger fract
ion of their populations in the G(0)/G(1) phase of the cell cycle than
control cells. All forms of bFGF were eluted from MCF-7/NCFFGF(18,22.
24) cell monolayers with 2 M NaCl, in contrast to fibroblasts that wer
e demonstrated to secrete only the 18-kD bFGF isoform. High-affinity b
inding of 18-kD I-125-bFGF to these cells was significantly decreased,
probably because of competitive binding by the autocrine-secreted bFG
F. Recombinant 18-kD bFGF that was previously demonstrated in our labo
ratory to inhibit proliferation, activate MAP kinase, and induce the c
yclin-dependent kinase inhibitor p21(WAF1/CIP1) in MCF-7 cells, furthe
r inhibited MCF-7/Delta A(FGF(18)) cells but had no effect on MCF-7/NC
FFGF(18,22,24) cells. The total cellular content of the high-affinity
FGF receptors 1-3 was unchanged, but FGF receptor 4 was decreased in M
CF-7/NCFFGF(18,22,24) cells. Both cell types overexpressing bFGF isofo
rms had elevated levels of the cyclin-dependent kinase inhibitor p27(K
ip1) but not that of p21(WAF1/CIP1). In MCF-7/Delta A(FGF(18)) cells,
FGFR1 and MAP kinase were constitutively phosphorylated. Exogenous rec
ombinant 18-kD bFGF did not accentuate these effects but did induce an
increase in the levels oi p21(WAF1/CIP1) corresponding to the further
inhibition induced by exogenous bFGF in these cells. In MCF-7/NCFFGF(
18,22,24) cells, FGFR1 and MAP kinase were not phosphorylated at basel
ine nor upon stimulation with recombinant bFGF, and exogenous bFGF onl
y had a minimal effect on low steady-state p21(WAF1/CIP1) levels. Howe
ver, stimulation of these cells with phorbol ester or insulin did resu
lt in MAP kinase phosphorylation. While growth-inhibited in the G(1) p
hase of the cell cycle, MCF-7/NCFFGF(18,22,24) cells retained active i
soforms of cdk2 and the hyperphosphorylated form oi Rb. These data sug
gest that high molecular weight forms of bFGF overexpressed in MCF-7 c
ells do not activate the receptor-mediated MAP kinase pathway, and do
not induce p21(WAF1/CIP1) in an autocrine manner, but inhibit prolifer
ation through other, possibly direct nuclear signalling mechanisms. (C
) 1998 Wiley Liss Inc.